Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals

Open access
Giovannucci, E., Rimm, E. B., Liu, Y., Leitzmann, M., Wu, K., Stampfer, M. J., Willett, W. C. · 2003 · JNCI Journal of the National Cancer Institute

Abstract

The relationship between body mass index (BMI) and prostate cancer risk may be complex because obesity is associated with various hormonal factors and because the influence of BMI may differ according to whether the cancers are hereditary or sporadic. We used data from the Health Professionals Follow-Up Study, in which 2896 incident cases of prostate cancer were reported from February 1, 1986, through January 31, 2000, to determine prospectively whether BMI was associated with the risk of hereditary (men <60 years of age or with a positive family history of prostate cancer) and sporadic (men > or =60 years of age and without such a family history) prostate cancer. The risk of prostate cancer in men with a higher BMI (> or =30 kg/m2) was lower than that in men with a lower BMI (23-24.9 kg/m2) but only if they were younger (<60 years old) (relative risk = 0.52, 95% confidence interval = 0.33 to 0.83; P(trend)<.001) or had a family history of prostate cancer (relative risk = 0.74, 95% confidence interval = 0.45 to 1.19; P(trend) =.01). However, for groups with more sporadic cancers, BMI had a weak, non-statistically significant positive association with prostate cancer. We observed statistically significant interactions between BMI and age (P(interaction)<.001, two-sided Wald test) and between BMI and family history of prostate cancer (P(interaction) =.006, two-sided Wald test). Patterns for BMI and waist circumference were similar. Because obesity is associated with lower circulating concentrations of testosterone, our results suggest the hypothesis that androgens may play a more direct role for early-onset or hereditary prostate cancers than for sporadic prostate cancers.

Overview

Integrity signals

Registry

Crossref · 10.1093/jnci/djg009

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Research works printed but not linked: 3

  1. Zumoff, 1988, Acta medica Scandinavica. Supplementum, 723, 153
  2. Giovannucci, 1997, Cancer Epidemiology Biomarkers & Prevention, 6, 557
  3. Giovannucci, 2002, Cancer Epidemiology Biomarkers & Prevention, 11, 985

Cited by

See all 260

Metadata

Authors
Giovannucci, E., Rimm, E. B., Liu, Y., Leitzmann, M., Wu, K., Stampfer, M. J., & Willett, W. C.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Giovannucci, E.
Venue
JNCI Journal of the National Cancer Institute
Published
2003-08-19
Volume
95
Issue
16
Pages
1240-1244
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2168533683
Cited by
258
References
29
Citations by year
2026: 3 · 2025: 2 · 2023: 4 · 2022: 7 · 2021: 2 · 2020: 3 · 2019: 7 · 2018: 2 · 2017: 5 · 2016: 12 · 2015: 15 · 2014: 13 · 2013: 11 · 2012: 14
FWCI
10.37
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JNCI Journal of the National Cancer Institute (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Funders
National Cancer Institute (CA055075)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Keywords
body mass index, obesity, prostate cancer, hereditary prostate cancer, sporadic prostate cancer, family history (medicine), waist circumference, androgens, testosterone, age interaction, Health Professionals Follow-up Study
MeSH terms
Adult, Aged, Health Personnel, Humans, Male, Middle Aged, Prospective Studies, Prostatic Neoplasms, Risk Factors, United States, Body Mass Index, Incidence, Multivariate Analysis, Age Distribution, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals. https://app.cochat.ai/papers/10.1093/jnci/djg009
The paper
Giovannucci, E., Rimm, E. B., Liu, Y., Leitzmann, M., Wu, K., Stampfer, M. J., & Willett, W. C. (2003). Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djg009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.